Alle patienter yngre end 16 år, som tager Viramune oral suspension, bør kontrolvejes eller have kontrolleret deres legemsoverflade regelmæssigt for at vurdere om dosisjustering er nødvendig.
All patients less than 16 years of age receiving VIRAMUNE oral suspension should have their weight or BSA checked frequently to assess if dose adjustments are necessary.